RCKT- Rocket Pharmaceuticals, Inc.

Name: Rocket Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Rocket Pharmaceuticals, Inc. (RCKT) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 14 sells. RCKT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Rtw Investments, LP	19.19M	$65.05M	-
CEO	Shah Gaurav	778.3K	$2.64M	-
COO	Stevens Christopher James	407.2K	$1.38M	-
Other	Wilson Martin	383.8K	$1.30M	-
Other	Schwartz Jonathan David	299.1K	$1.01M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 2, 2026	Bjork Elisabeth	Director	Buy	10,000	$3.44	$34,400.00	+25.0%	+2.6%	-
Nov 18, 2025	Militello John72	See Remarks	Sell	1,086	$2.98	$3,239.54	-1.6%	+12.6%	-
Nov 18, 2025	Shah Gaurav71	CEO	Sell	6,276	$2.98	$18,721.31	-0.8%	+12.6%	-
Nov 18, 2025	Wilson Martin85	General Counsel	Sell	1,646	$2.98	$4,910.02	-0.4%	+12.6%	-
Nov 18, 2025	Schwartz Jonathan David72	See Remarks	Sell	2,545	$2.98	$7,591.74	-0.8%	+12.6%	-
Oct 14, 2025	Militello John72	See Remarks	Sell	28,918	$3.96	$114,581.27	-9.3%	-15.7%	-
Aug 27, 2025	Bjork Elisabeth	Director	Buy	10,000	$3.41	$34,100.00	+33.3%	-6.6%	-
Aug 19, 2025	Militello John72	See Remarks	Sell	1,060	$3.04	$3,223.99	-0.9%	+4.5%	-
Aug 19, 2025	Schwartz Jonathan David72	See Remarks	Sell	2,485	$3.04	$7,560.98	-0.6%	+4.5%	-
Aug 19, 2025	Wilson Martin85	General Counsel	Sell	1,592	$3.04	$4,838.91	-0.6%	+4.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC